News
Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...
Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...
Stock futures edged higher on Tuesday (July 29) after the S&P 500 and Nasdaq Composite notched fresh record highs, even as ...
Carvana is scheduled to report earnings after the closing bell Wednesday, with traders expecting a big move from the used car ...
Every investor aims to build a portfolio that grows steadily and delivers meaningful returns. Growth investing remains a time ...
Sarepta Therapeutics ( NASDAQ: SRPT) was upgraded to Neutral from Underweight at J.P. Morgan as it sees FDA's Elevidys hold removal recommendation in ambulatory patients as a clear win.
StockStory.org on MSN48m
5 Must-Read Analyst Questions From Selective Insurance Group’s Q2 Earnings CallSelective Insurance Group’s second quarter results were met with a negative market reaction, as the company’s non-GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results